Device Trial Radar · NCT06893588
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Apr 14, 2025
Primary completion
Feb 14, 2027
Study completion Mar 15, 2027
Sponsor
- Lead sponsor
- VesalioNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 25, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Conditions
- Cerebral Vasospasm
- Aneurysmal Subarachnoid Hemorrhage (aSAH)
Interventions
NEVA VSDevice
cerebral artery dilation device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement in target vessel diameter following NeVa VS useTime frame: Up to 1 hour post procedure
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Providence St. Joseph Medical Center
Burbank, California · Recruiting
John Muir Health
Walnut Creek, California · Recruiting
Yale
New Haven, Connecticut · Recruiting
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.